AI radiology tool market seen reaching $3.69 billion by 2030

The global market for AI radiology tools is projected to rise to $3.69 billion by 2030, driven by precision medicine, cloud-based platforms and broader use of automated imaging workflows. North America led the market in 2025, while the report points to growing regulatory approvals and investment in AI imaging.

Why it matters: - AI radiology tools are becoming a core part of medical imaging, with the potential to improve diagnostic accuracy, speed and workflow efficiency. - The market’s growth signals rising demand for tools that can help radiologists manage heavier imaging volumes and support more personalized care. - Broader adoption could affect healthcare costs, treatment timelines and access to advanced diagnostics.

What happened: - The Business Research Company projected the global AI radiology tool market will grow from $1.74 billion in 2025 to $2.05 billion in 2026. - The report forecasts the market will reach $3.69 billion by 2030. - The company said the market is expanding as healthcare systems adopt AI to support radiology interpretation and reporting. - The report was published as part of The Business Research Company’s Artificial Intelligence (AI) Radiology Tool Global Market Report 2026. - More information is available in the full report.

The details: - The market is projected to post a 17.8% compound annual growth rate in the near term from 2025 to 2026. - The report forecasts a 15.8% compound annual growth rate through 2030. - Historical growth has been supported by rising medical imaging volumes, a shortage of radiologists, early adoption of computer-aided detection systems and improvements in digital radiology infrastructure. - Future growth is expected to come from cloud-based AI platforms, precision diagnostics, broader use in interventional radiology, automated reporting systems and more regulatory approvals for AI imaging technologies. - AI radiology tools analyze X-rays, CT scans, MRI scans and ultrasounds to detect abnormalities, identify patterns and generate quantitative insights. - The tools are designed to improve the accuracy, speed and effectiveness of medical image interpretation. - The report says these tools can also help reduce healthcare costs and improve patient outcomes. - North America was the largest AI radiology tool market in 2025. - The report also covers Asia-Pacific, Southeast Asia, Western and Eastern Europe, South America, the Middle East and Africa. - North America’s lead is tied to advanced healthcare infrastructure, faster technology adoption and investment in AI research and development for medical imaging. - The report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables. - A free sample is available here.

Between the lines: - Personalized medicine is emerging as a major demand driver because it requires more precise diagnostics and treatment targeting. - AI radiology tools fit that shift by offering predictive analytics, real-time treatment monitoring, genomic data integration and better patient stratification. - The report pointed to FDA approvals of 16 new personalized therapies for rare diseases in 2023, up from six in 2022, as evidence of growing momentum behind tailored medicine. - That trend suggests radiology AI is gaining relevance beyond imaging alone and into broader precision-care workflows.

What's next: - The report expects wider use of AI-powered image interpretation and workflow automation in radiology departments. - It also points to continued advances in early anomaly detection and AI-assisted diagnostic accuracy. - More regulatory approvals could accelerate adoption across hospitals and imaging centers. - Continued investment in cloud infrastructure and automated reporting systems may help scale deployment.

The bottom line: - AI radiology is moving from a niche imaging add-on to a fast-growing healthcare software category with a projected multi-billion-dollar market by 2030.